Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease. - Zeiser R; Polverelli N; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hollaender N; Gowda M; et al. (New England Journal Of Medicine, 2021)